Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Clinical trial NCT01110720 · COMPLETED
Trial details
- NCT number
- NCT01110720
- Sponsor
- Allon Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2012-11-01
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.